Afya (AFYA) EBITDA (2018 - 2026)

Afya has reported EBITDA for 9 years, with the latest figure at $74.8 million in Q1 2026.

• Quarterly EBITDA rose 17.64% year-over-year to $74.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $227.6 million (up 17.01% YoY) and the FY2025 annual result came in at $217.3 million, up 15.07% from the prior year.
• EBITDA grew to $74.8 million in Q1 2026 per AFYA's latest filing, from $51.6 million in the prior quarter.
• Over five years, EBITDA peaked at $74.8 million in Q1 2026 and troughed at $27.9 million in Q3 2022.
• A 5-year average of $44.9 million and a median of $44.2 million in 2023 frame the typical range for EBITDA.
• The sharpest annual moves came in 2022 and 2023: EBITDA soared 98.63% in 2022, then grew 2.66% in 2023.
• Over 5 years, EBITDA stood at $28.0 million in 2022, then gained by 23.26% to $34.5 million in 2023, then gained by 28.86% to $44.4 million in 2024, then grew by 16.1% to $51.6 million in 2025, then surged by 45.07% to $74.8 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered $74.8 million, $51.6 million, and $50.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.